Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opiranserin-Based Multimodal Analgesia for Opioid-Free Recovery After Cholecystectomy
KCT0012386Phase 4Not yet recruiting
- Sponsor
- Korea University Anam Hospital
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of opiranserin in cholecystitis, sponsored by Korea University Anam Hospital. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
opiranserin
03
Conditions
cholecystitis
Beyond the preview
Go deeper on KCT0012386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012386.